Understanding how osteosarcoma spreads to the lungs
Epigenetic drivers of lung metastasis in osteosarcoma
This study is looking at how bone cancer, called osteosarcoma, spreads to the lungs, and it aims to find new ways to stop this from happening, which could help patients get better treatments for their cancer.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10995632 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind lung metastasis in osteosarcoma, a type of bone cancer that often spreads to the lungs. The study focuses on specific transcription factors and epigenetic changes that enable cancer cells to migrate and establish themselves in the lung tissue. By analyzing these factors, the researchers aim to identify potential targets for new therapies that could prevent or treat metastatic disease. Patients may benefit from insights that lead to more effective treatments tailored to their specific cancer subtype.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults diagnosed with osteosarcoma, particularly those experiencing or at risk for lung metastasis.
Not a fit: Patients with osteosarcoma who do not have lung metastasis or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies that significantly improve survival rates for patients with metastatic osteosarcoma.
How similar studies have performed: Previous research has shown promise in understanding the genetic and epigenetic factors involved in cancer metastasis, suggesting that this approach could yield valuable insights.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Chin, Diana — Case Western Reserve University
- Study coordinator: Chin, Diana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.